Christina J. Yang

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/ffe6dfe0-5ef2-11ec-bfce-d5e3d9116b93.jpg

First Name

Christina

Last Name

Yang

NPI

1295996486

Faculty ID

14783

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<div>
<div><span style="font-size: medium;"><span><span style="color: black;">Dr. Yang treats common pediatric otolaryngology problems including otitis media, obstructive sleep apnea, and tonsillitis. She underwent specialized fellowship training in the diagnosis and treatment of airway and swallowing disorders and also has a special interest in tracheostomy care and education.</span></span></span></div>
<div><span style="font-size: medium;"><span><span style="color: black;">Education:</span></span></span></div>
<div><span style="font-size: medium;"><span><span style="color: black;"><span>Clinical fellowship in Pediatric Otolaryngology: Cincinnati Children&rsquo;s Hospital Medical Center</span></span></span></span></div>
<div>&nbsp;</div>
<div><span style="font-size: medium;"><span><span style="color: black;">R<span>esidency in Otolaryngology-Head and Neck Surgery: Tulane University School of Medicine&nbsp;</span></span></span></span></div>
<div><span style="font-size: medium;"><span><span style="color: black;">Medical School: Northwestern University Feinberg School of Medicine (</span></span></span><span style="font-size: medium;">Honors Program in Medical Education (HPME))</span></div>
<div><span style="font-size: medium;"><br /></span></div>
<div><span style="font-size: medium;">Dr. Yang has been on faculty at Albert Einstein College of Medicine / Montefiore Medical Center / the Children&rsquo;s Hospital at Montefiore since 2015, focusing her efforts on quality improvement and multidisciplinary care for complex children including neonates and those with airway and swallowing issues. She is active in national societies including the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and the American Society of Pediatric Otolaryngology (ASPO).</span></div>
<div><span style="font-size: medium;"><br /></span></div>
</div>
<div>
<div><span style="font-size: medium;"><span><span style="color: black;">Languages: English. Limited French and Mandarin Chinese.</span></span></span></div>
</div>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Dr. Yang&rsquo;s clinical interests include airway and swallowing disorders in children, endoscopic and open airway reconstruction and tracheotomy.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Yang&rsquo;s research focuses on the application of healthcare simulation to medical education, patient safety, quality improvement and implementation science.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

PubMed.gov URL

EMR ID

78578

Biography

<p>Christina J. Yang, MD, is Director, Pediatric Dysphagia Program; Associate Director, Pediatric Otolaryngology Quality Assurance and Assistant Professor at Montefiore-Einstein. Dr. Yang&rsquo;s clinical interests include airway and swallowing disorders in children, endoscopic and open airway reconstruction and tracheotomy.</p><p>A graduate of Northwestern University, Dr. Yang received her Bachelor of Arts in 2004, and continued at the institution&rsquo;s Feinberg School of Medicine, earning her Doctor of Medicine in 2008. She began her postdoctoral education at Tulane University School of Medicine, completing her residency in otolaryngology&ndash;head and neck surgery in 2013. She then pursued a fellowship in pediatric otolaryngology at Cincinnati Children&rsquo;s Hospital Medical Center, completing it in 2015.</p><p>Dr. Yang&rsquo;s research focuses on the application of healthcare simulation to medical education, patient safety, quality improvement and implementation science. Her work has been published in a number of journals and book chapters, and presented internationally. She is also a reviewer for the <em>International Journal of Pediatric Otorhinolaryngology, The Laryngoscope and the Journal of Otology</em>.</p><p>Dr. Yang is board certified by the American Board of Otolaryngology and a member of numerous professional societies, including the American Society of Pediatric Otolaryngology and the American Academy of Otolaryngology&ndash;Head and Neck Surgery.</p>

Is Open Scheduling

On

Zocdoc Link

Alanna M. Windsor

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/3a9dff40-24ce-11ee-88ab-4d123afddc94.jpg

First Name

Alanna

Last Name

Windsor

NPI

1376980961

Faculty ID

16897

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

141714

Is Open Scheduling

On

Daniel A. Weiser

https://assets.montefioreeinstein.org/profiles/images/Weiser_Daniel_MD_2x.jpg

First Name

Daniel

Last Name

Weiser

NPI

1225239700

Faculty ID

13846

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="text-decoration: underline;"><strong>Childhood cancer research laboratory</strong></span></p>
<p>Our laboratory is focused on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. In such patients with typically incurable cancer, we are striving to identify new approaches to and types of treatment. We have multiple ongoing projects:</p>
<p><strong>+ Identification of biologic drivers of ultra-high-risk neuroblastoma</strong>. Neuroblastoma is one of the most common and deadly childhood cancers. Despite intensive research, there are limited therapeutic strategies for patients with <em>de novo </em>chemotherapy resistance that leads to particularly poor outcomes. We have been studying neuroblastoma since 2009 and are identifying additional biologic drivers of highly lethal tumors.</p>
<p>We compare tumor features from patients with early death from tumor progression compared to those with a maintained complete response. We assess unique histo-morphologic and proteomic features and computationally integrate these data with genomic and transcriptomic datasets to develop a combined predictor of primary refractory disease. Patients with this entity require non-standard and/or intensified treatment. Oncogenic drivers are being characterized in the lab which will facilitate strategies for novel pharmacologic intervention.</p>
<p><strong>+ Characterization of neuroblastoma development from neural crest cells</strong>.&nbsp; We are studying pathways and interactions that results in uncontrolled cell proliferation early in neuroblastoma development with an ultimate goal of identifying new targets and approaches for pharmacologic intervention.</p>
<p><strong>+ Evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma</strong>.&nbsp; With expected outcomes lagging behind those of more common childhood cancers, children with neuroblastoma require new approaches to treatment. Our lab works with multiple international clinical and research consortium groups to perform preclinical studies that substantiate human clinical trials.&nbsp;</p>
<p><strong>+ Detection of circulating tumor DNA in osteosarcoma</strong>. With no reliable non-invasive approach for disease monitoring during and after treatment, we are applying cutting edge next-generation sequencing approaches to identify solid tumors with a blood-based &ldquo;liquid&rdquo; biopsies. This will allow clinicians to assess tumor responsiveness to chemotherapy and predict likelihood of recurrence.</p>
<p><strong>+ Assessment of accelerated aging using miRNA-seq in survivors of childhood cancer</strong>. Chemotherapy has many untoward effects on healthy cells and leads to many signs of accelerated aging in children treated for cancer. Using a known microRNA &ldquo;aging&rdquo; signature discovered at Albert Einstein College of Medicine, we are studying what causes this phenotype in childhood cancer, with a goal of offering improved intervention to minimize long-term toxicity of treatment.</p>
<p><strong><span style="text-decoration: underline;">Physician Summary</span></strong></p>
<p>Daniel A. Weiser, MD, is board-certified in pediatric hematology/oncology with clinical expertise in neuroblastoma and other tumors of the adrenal glands, kidneys, liver, and gonads. He is the medical director of the intra-abdominal solid tumor program at the Children&rsquo;s Hospital at Montefiore and brings together a highly specialized multi-disciplinary care team to provide comprehensive treatment for diverse pediatric malignancies. In addition, Dr. Weiser directs a childhood cancer research laboratory that focuses on the identification of new targeted agents for cancer therapy, especially in the treatment of rare and aggressive malignancies such as neuroblastoma. His research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise for improving management of all patients with solid tumors.</p>
<p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Advances in Neuroblastoma Research Association (ANRA), National Pediatric Cancer Foundation (NPCF), and the American Academy of Pediatrics (AAP). He has received numerous awards including the Brigid Leventhal Special Merit Award from ASCO and the Conquer Cancer Foundation, and a prestigious K12 from the National Cancer Institute for the training of the next generation of physician-scientists in pediatric cancer. Dr. Weiser is actively involved in teaching and mentorship of trainees, and takes great pride in providing advanced and compassionate care to his patients and their families.</p>
<p><strong>Clinical Expertise</strong></p>
<ul>
<li>Neuroblastoma (adrenal tumors)</li>
<li>Wilms tumor (renal tumors)</li>
<li>Hepatoblastoma (liver tumors)</li>
<li>Germ cell tumors (including testicular and ovarian tumors)</li>
<li>Thyroid and other rare tumors</li>
<li>Experimental therapeutics</li>
<li>Cancer genetics and biomarkers</li>
</ul>
<p><strong>Board Certifications</strong></p>
<ul>
<li>Pediatrics</li>
<li>Pediatric Hematology/Oncology</li>
</ul>
<p><strong>Professional Education</strong></p>
<ul>
<li>M.D. &ndash; Stony Brook University, NY</li>
<li>Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Chief Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Fellowship &ndash; The Children&rsquo;s Hospital of Philadelphia, PA</li>
</ul>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

DR. Weiser's clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma, and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers.&nbsp;

Research Focus

Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others.

Elsevier Profile

EMR ID

5755

Biography

<p>Daniel A. Weiser, MD, is a Medical Director of the Intra-abdominal Solid Tumor Program in the Pediatrics Hematology/Oncology department at Children&rsquo;s Hospital at Montefiore. He is also Associate Professor in the Pediatrics and Genetics departments at the Albert Einstein College of Medicine. His clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers. Dr. Weiser is actively involved in teaching and mentorship of trainees and takes great pride in his active participation in patient care.</p><p>Dr. Weiser received his Bachelor of Science in Neurobiology in 1995 at Haverford College, PA. In 2004, he received his Doctor of Medicine at Stony Brook University School of Medicine, NY. He is currently earning his Master of Science in Translational Research at the University of Pennsylvania. He began a residency in Pediatrics at the New York-Presbyterian, Columbia University in 2007. Dr. Weiser then completed a three-year fellowship in Pediatric Hematology/Oncology at The Children&rsquo;s Hospital of Philadelphia. </p><p>Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others. His research has been published in many reviewed journals. </p><p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), and the American Academy of Pediatrics (AAP). He has received many awards including the Brigid Leventhal Special Merit Award through ASCO, and he has been awarded a prestigious K12 from the NCI for the training of the next generation of physician-scientists in pediatric cancer.</p><p>He is board certified in Pediatric Hematology/Oncology and General Pediatrics.</p>

Is Open Scheduling

Off

Brian D. Spund

https://assets.montefioreeinstein.org/profiles/images/physphoto/Spund_Brian_D._MD_11121354.jpg

First Name

Brian

Last Name

Spund

NPI

1629377320

Faculty ID

15059

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

68828

Is Open Scheduling

Off

Scott J. Schafler

https://assets.montefioreeinstein.org/profiles/images/Scott-Schafler.jpg

First Name

Scott

Last Name

Schafler

NPI

1417219585

Faculty ID

16440

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

55639

Is Open Scheduling

Off

Elizabeth D. Romney

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Elizabeth

Last Name

Romney

NPI

1063892818

Faculty ID

16559

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

52626

Is Open Scheduling

On

Zocdoc Link

Samuel J. Rednor

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Samuel

Last Name

Rednor

NPI

1265775167

Faculty ID

16224

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Nephrology and Critical Care.

Research Focus

Dr. Rednor&rsquo;s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation.&nbsp;

Elsevier Profile

EMR ID

87716

Biography

<p>Samuel J. Rednor, DO, is Director of Wellness, Critical Care and Assistant Professor, Medicine at Montefiore Einstein. His clinical focus is nephrology and critical care.</p><p>After earning his Doctor of Osteopathic Medicine at Lake Erie College of Osteopathic Medicine in 2013, Dr. Rednor completed his residency in internal medicine at Southampton Hospital in 2016, where he was Chief Resident for one year. He then completed his renal fellowship at Montefiore in 2018, where he was Chief Renal Fellow during his last year. Dr. Rednor went on to complete an additional fellowship at Montefiore in critical care, which he completed in 2019.</p><p>Dr. Rednor&rsquo;s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation. His work has been published in peer-reviewed journals and he has given multiple lectures and presentations.</p><p>Dr. Rednor is board certified in Internal Medicine, Nephrology and Critical Care Medicine by the American Osteopathic Board of Internal Medicine. He is a member of the American Society of Nephrology (ASN), the American Osteopathic Association (AOA), the Society of Critical Care Medicine (SCCM) and the American College of Chest Physicians (CHEST). In 2018, Dr. Rednor won the Sharon R. Silbiger Teaching Award for excellence in teaching and in recognition as Outstanding Fellow of the Year from Einstein.</p>

Is Open Scheduling

Off

Deborah Orsi

https://assets.montefioreeinstein.org/profiles/images/13514-deborah-orsi.jpg

First Name

Deborah

Last Name

Orsi

NPI

1104025899

Faculty ID

13514

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5212

Is Open Scheduling

Off

Moyses Niremberg

https://assets.montefioreeinstein.org/profiles/images/physphoto/Niremberg_Moyses_MD_420x504.jpg

First Name

Moyses

Last Name

Niremberg

NPI

1861599698

Faculty ID

2623

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4337

Is Open Scheduling

Off

Michel Nassar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/e21f1a40-bb36-11ec-bd24-2927171ec855.jpg

First Name

Michel

Last Name

Nassar

NPI

1851646558

Faculty ID

14086

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA).<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR).<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

5768

Biography

<p>Michel Nassar, MD, MSc, is Director, AeroDigestive Program at Children&rsquo;s Hospital at Montefiore, and Co-Director, CranioFacial Clinic and Associate Professor of Otolaryngology at Montefiore-Einstein. Dr. Nassar takes a multidisciplinary approach to patients with complex aerodigestive disease. His clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA). He also has expertise in the medical and surgical management of velopharyngeal disorders.</p><p>Dr. Nassar earned his medical degree at Saint Joseph University in Beirut, Lebanon in 2005. He began his postgraduate training in France, completing an otolaryngology residency at Hotel Dieu de France Hospital in 2010 and his Masters in Surgical Sciences and pediatric otolaryngology fellowship in 2012. He then came to the United States, completing a pediatric otolaryngology fellowship at Cincinnati Children&rsquo;s Hospital in 2013.</p><p>In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR). His work has been shared through peer-reviewed journals and oral presentations. He is also a reviewer for <em>Laryngoscope, the International Journal of Pediatric Otorhinolaryngology and the European Annals of Otorhinolaryngology</em>.</p><p>Dr. Nassar is a member of the American Academy of Otolaryngology&ndash;Head and Neck Surgery, the American Academy of Pediatrics and the International Federation of Oto-Rhino-Laryngological Societies. He has been listed among the <em>New York Times</em>&rsquo; Super Doctors - Rising Stars.</p>

Is Open Scheduling

On

Zocdoc Link